Banner for leaf pages 2

Rufinamide (Banzel)

Also known as Banzel

Rufinamide is an anticonvulsant medication. It is used in combination with other medication and therapy to treat Lennox–Gastaut syndrome and various other seizure disorders. Rufinamide, a triazole derivative, was developed in 2004 by Novartis Pharma, AG, and is manufactured by Eisai.

Source: Wikipedia

Estimated Total Cost: $705.76 for an average of 28 days supply

What is it prescribed for?

Patients are most commonly prescribed rufinamide to treat epilepsy, seizures, blastomycosis, and rabies.

What drug interactions are known?

Do not take rufinamide if you are taking any of the following:

Critical Interactions

Significant Interactions

What side effects are related?

Patients taking rufinamide most commonly experience side effects like headache, fatigue, and vomiting.

Ajax-loader Loading...